These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

959 related items for PubMed ID: 828142

  • 21. [Prediction of fetal blood group from amniotic fluid and use in hemolytic disease of the newborn (author's transl)].
    Qian ML.
    Zhonghua Fu Chan Ke Za Zhi; 1982 Jan; 17(1):21-3. PubMed ID: 6807636
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [On the serological diagnosis of ABO erythroblastosis].
    Bube FW.
    Z Kinderheilkd; 1966 Feb 18; 95(3):231-6. PubMed ID: 4965215
    [No Abstract] [Full Text] [Related]

  • 24. Haemolytic disease of the newborn due to Rh-isoimmunization: the role of free anti-D antibodies in bilirubin rebound.
    Pataki L.
    Acta Paediatr Acad Sci Hung; 1970 Feb 18; 11(3):219-29. PubMed ID: 5004392
    [No Abstract] [Full Text] [Related]

  • 25. [Serology and prophylaxis of Rhesus-caused hemolytic disease of the newborn].
    Maresch W.
    Wien Med Wochenschr; 1966 Nov 11; 116(46):972-4. PubMed ID: 4966249
    [No Abstract] [Full Text] [Related]

  • 26. Haemolytic disease of newborn.
    Narang A, Jain N.
    Indian J Pediatr; 2001 Feb 11; 68(2):167-72. PubMed ID: 11284186
    [Abstract] [Full Text] [Related]

  • 27. [The RH-conflict and its position in present-day obstetrics].
    Möbius W, Krause W, Kadner J.
    Zentralbl Gynakol; 1973 Sep 21; 95(38):1329-36. PubMed ID: 4203838
    [No Abstract] [Full Text] [Related]

  • 28. [Problems of children with hemolytic disease of the newborn, caused by Rh and ABO blood group incompatibility, treated by exchange transfusion].
    Osuch-Jaczewska R, Boruta E, Baumert M, Paprotny M, Jerzykiewicz-Dziuba K, Giec-Fuglewicz G.
    Acta Haematol Pol; 1988 Sep 21; 19(3-4):153-9. PubMed ID: 3150889
    [No Abstract] [Full Text] [Related]

  • 29. [Rhesus incompatibility and anti-D prevention in the Düsseldorf region (a ten-year survey) (author's transl)].
    Göbel U, Haering M, Fertmann J, Voss HV, Petrich C.
    Dtsch Med Wochenschr; 1975 Oct 03; 100(40):2010-3. PubMed ID: 808407
    [Abstract] [Full Text] [Related]

  • 30. [Correlation between the presence of cytotoxic anti-HL-A antibodies in the clinical course of hemolytic disease of the newborn infant due to anti-Rh (D) or immune anti-A/B erythrocyte antibodies].
    Gligorović VN, Gligorović S, Susaković N, Lopicić L, Stolić I, Marković V, Matejić T.
    Bilt Hematol Transfuz; 1976 Oct 03; 4(3):23-31. PubMed ID: 827283
    [Abstract] [Full Text] [Related]

  • 31. [Prevention of Rh sensitization by means of anti D application].
    Schneider J.
    Bibl Haematol; 1969 Oct 03; 32():113-23. PubMed ID: 4980798
    [No Abstract] [Full Text] [Related]

  • 32. [Serum ABO immune antibodies in 1944 pregnant women].
    Wan MR.
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jan 03; 26(1):12-4, 60-1. PubMed ID: 1900749
    [Abstract] [Full Text] [Related]

  • 33. Laboratory identification of erythroblastosis fetalis.
    Kurtz EM, Pappas AA, Cannon A.
    Ann Clin Lab Sci; 1982 Jan 03; 12(5):388-97. PubMed ID: 6814344
    [Abstract] [Full Text] [Related]

  • 34. Hemolytic disease.
    Freda V.
    Clin Obstet Gynecol; 1973 Mar 03; 16(1):72-102. PubMed ID: 4196840
    [No Abstract] [Full Text] [Related]

  • 35. [Rh factor: anti-D isoimmunization and its therapeutic possibilities].
    Tucci G, Teofili MT.
    Clin Ter; 1967 Dec 31; 43(6):567-89. PubMed ID: 4979582
    [No Abstract] [Full Text] [Related]

  • 36. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA, Ryan G, Seaward PG, Kelly EN, Fernandes BJ.
    Transfusion; 2004 Sep 31; 44(9):1357-60. PubMed ID: 15318861
    [Abstract] [Full Text] [Related]

  • 37. [Current data and contribution to the study of hemolytic disease caused by feto-maternal blood incompatibility].
    Trifan N, Lupaşcu G, Trifan E.
    Rev Med Chir Soc Med Nat Iasi; 1971 Sep 31; 75(4):1049-54. PubMed ID: 4135203
    [No Abstract] [Full Text] [Related]

  • 38. [Bilirubin and brain injury].
    Takahashi S, Wada M, Kimura E.
    Ryoikibetsu Shokogun Shirizu; 2000 Sep 31; (30 Pt 5):455-61. PubMed ID: 11057283
    [No Abstract] [Full Text] [Related]

  • 39. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
    Altuntas N, Yenicesu I, Himmetoglu O, Kulali F, Kazanci E, Unal S, Aktas S, Hirfanoglu I, Onal E, Turkyilmaz C, Ergenekon E, Koc E, Atalay Y.
    Transfus Apher Sci; 2013 Jun 31; 48(3):377-80. PubMed ID: 23619329
    [Abstract] [Full Text] [Related]

  • 40. Erythroblastosis fetalis: identification, management, and prevention.
    Frigoletto FD, Umansky I.
    Clin Perinatol; 1979 Sep 31; 6(2):321-30. PubMed ID: 117965
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.